Home › Mesothelioma › New Jersey
Mesothelioma clinical trials in New Jersey
8 studies for Mesothelioma are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Astera, LLC, East Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06057935Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only ), Montvale
Recruiting
Ages 30 to 85 · All sexes · Updated Sep 24, 2026 · NCT06037941Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366CT-95 in Advanced Cancers Associated With Mesothelin Expression
- Context Investigational Site, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035A Study of Sacituzumab Govitecan in People With Mesothelioma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT06477419VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.